Adult respiratory distress syndrome and renal failure associated with citalopram overdose

被引:13
作者
Kelly, CA [1 ]
Upex, A
Spencer, EP
Flanagan, RJ
Bateman, DN
机构
[1] Royal Infirm Edinburgh NHS Trust, Scottish Poisons Informat Bur, Edinburgh EH16 4SU, Midlothian, Scotland
[2] Guys & St Thomas Hosp Trust, Med Toxicol Unit, London, England
关键词
acute lung injury; adult respiratory distress syndrome; citalopram; renal failure;
D O I
10.1191/0960327103ht327cr
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
A 45-year-old man ingested 3000 mg of citalopram hydrobromide (2400 mg citalopram). He presented to the Emergency Department 2 hours post-ingestion with a pulse of 100 beats/min and blood pressure of 120/80 mmHg. His electrocardiogram (ECG) was normal. Chest X-ray showed bilateral shadowing, with no evidence of aspiration of gastric contents. Shortly after, he had three tonic-clonic seizures, requiring intravenous diazepam. Eight hours post-ingestion he became oliguric with deteriorating renal function, despite normal arterial and central venous pressures. He became increasingly hypoxic, with chest X-ray changes compatible with adult respiratory distress syndrome (ARDS). Despite treatment with 100% oxygen and continuous positive airway pressure, his gas exchange continued to deteriorate, requiring intubation and ventilation. His renal function also deteriorated with a peak creatinine of 492 mumol/L on day 4 in the absence of rhabdomyolysis. There was complete spontaneous recovery of renal function after 2 weeks. A peak plasma total citaloprain (R+S enantiomers) concentration of 1.92 mg/L was recorded 2 hours post-ingestion. Total norcitalopram concentrations continued to rise up to 24 hours post-ingestion. Citalopram has been associated with seizures, ECG abnormalities, rhabdomyolysis and coma after overdose. The renal and respiratory complications seen in this patient have not been reported previously.
引用
收藏
页码:103 / 105
页数:3
相关论文
共 9 条
[1]
THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[2]
Acute lung failure induced by tricyclic antidepressants [J].
Dahlin, KL ;
Lastbom, L ;
Blomgren, B ;
Ryrfeldt, A .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 146 (02) :309-316
[3]
Symptoms and signs of severe citalopram overdose [J].
Grundemar, L ;
Wohlfart, B ;
Lagerstedt, C ;
Bengtsson, F ;
Eklundh, G .
LANCET, 1997, 349 (9065) :1602-1602
[4]
GUHAROY SR, 1994, VET HUM TOXICOL, V36, P316
[5]
KRAGHSORENSEN P, 1981, ACTA PHARMACOL TOX, V48, P53
[6]
Fatal overdose with citalopram [J].
Ostrom, M ;
Eriksson, A ;
Thorson, J ;
Spigset, O .
LANCET, 1996, 348 (9023) :339-340
[7]
Citalopram overdose - Review of cases treated in Swedish hospitals [J].
Personne, M ;
Sjoberg, G ;
Persson, H .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1997, 35 (03) :237-240
[8]
Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? [J].
Rasmussen, BB ;
Brosen, K .
THERAPEUTIC DRUG MONITORING, 2000, 22 (02) :143-154
[9]
ADULT RESPIRATORY-DISTRESS SYNDROME FROM OVERDOSE OF TRICYCLIC ANTIDEPRESSANTS [J].
VARNELL, RM ;
GODWIN, JD ;
RICHARDSON, ML ;
VINCENT, JM .
RADIOLOGY, 1989, 170 (03) :667-670